Trigger Point Injections for Post-Mastectomy Pain Syndrome

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

November 30, 2023

Study Completion Date

February 15, 2024

Conditions
Post-mastectomy Pain SyndromeMyofascial Pain SyndromeTrigger Point Pain, MyofascialBreast Cancer
Interventions
PROCEDURE

Trigger point injection

1mL injections of 1% lidocaine in the muscles identified active trigger points at the day of intervention (pectoralis major, serratus anterior, levator scapulae, latissimus dorsi, infraspinatus).

PROCEDURE

Subcutaneous saline injection

0.2mL subcutaneous saline injections superficial to the muscles identified with active trigger points at the day of intervention (pectoralis major, serratus anterior, levator scapulae, latissimus dorsi, infraspinatus).

OTHER

Comprehensive Rehabilitation program

Patients in both groups will undergo standard of care rehabilitation delivered by a Physiatrist, which may include Physical Therapy, Occupational Therapy, Exercise Physiologist, Rehabilitation Nurse, Psychologist, as per Physiatrist's prescription. Both the comprehensive rehabilitation program and pain medications will continue to be managed by participant's Physiatrist, who will be blinded to patient's allocation. The researchers will be responsible for TPI and for data collection.

Trial Locations (2)

Unknown

Hospital de Câncer de Barretos, Barretos

Instituto do Câncer do Estado de São Paulo, São Paulo

All Listed Sponsors
collaborator

Hospital de Câncer de Barretos

OTHER

lead

Instituto do Cancer do Estado de São Paulo

OTHER